Amanda Brady, PhD candidate in the Lawrenz Lab at the University of Louisville, is the newest T32 Fellow in the Inflammation and Pathogenesis Training Program at UofL. She was awarded a two year fellowship beginning July, 2021 to continue her studies into the role of inflammatory lipids during plague infection.
